Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

Drug Category :
Conference Category :
Lead Author : Robertson D, et al.
Published Date : 29/05/2026
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2026/05/Frontiers-in-Immunology-Treatment-Naive-5.29.26.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top